MEM_FIZZ

Mechanics of ESCRT-III mediated membrane scission

 Coordinatore UNIVERSITY OF BRISTOL 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 1˙499˙655 €
 EC contributo 1˙499˙655 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2010-StG_20091118
 Funding Scheme ERC-SG
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-10-01   -   2016-01-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITY OF BRISTOL

 Organization address address: TYNDALL AVENUE SENATE HOUSE
city: BRISTOL
postcode: BS8 1TH

contact info
Titolo: Dr.
Nome: Suman
Cognome: Peel
Email: send email
Telefono: +44 117 94640016

UK (BRISTOL) hostInstitution 1˙499˙655.00
2    UNIVERSITY OF BRISTOL

 Organization address address: TYNDALL AVENUE SENATE HOUSE
city: BRISTOL
postcode: BS8 1TH

contact info
Titolo: Mrs.
Nome: Sarah
Cognome: Everett-Cox
Email: send email
Telefono: +44 117 3311482

UK (BRISTOL) hostInstitution 1˙499˙655.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

chmps    formed    assemblies    form    cytosolic    pore    bound    escrt    intervention    binding    chmp    mechanism    structures    protein    therapeutic    hiv    scission    yeast    neck    membrane    membranes    human    snf    vps    proteins   

 Obiettivo del progetto (Objective)

'Cellular processes such as cytokinesis, the budding of enveloped retrovirus (e.g. HIV-1), and multivesicular biogenesis have direct links to several human diseases including carcinogenesis and neuro-degeration etc. While seemingly unrelated, these processes all involve membrane abscission for generating two newly formed membrane bound structures - a process aided by the cytosolic proteins collectively termed ESCRT-III. Understanding these processes for therapeutic intervention has so far focused on identification of the factors involved, their structures, and the interactions between them. However, given that membrane-abcission is the key event in all these processes, the mechanics of membrane scission cannot be neglected. Due to fast and highly localised transformations, protein mediated membrane remodelling in general has proven difficult for quantitative mechanistic scrutiny (perhaps with the single exception of dynamin which, unlike the ESCRT-III, acts from the outside of a membrane neck). In humans ESCRT-III members are called CHMPs. Major advances have been recently made in (i) determination of polymeric structures formed by human (yeast) CHMP4 (Snf7), CHMP3 (vps24) and CHMP2A; (ii) membrane splitting activity has been attributed to the sequential binding of the yeast proteins vps20 (CHMP6), Snf7 and vps24, (iii) vps2 (CHMP2), which binds vps24, recruits a AAA ATPAse vps4 which then recycles the membrane bound ESCRT-III. Several models have since been proposed where protein polymers constricting the membrane neck for fission is the common theme. However, there is considerable debate over the essential molecular mechanism of the process. Therefore, I will address: 1. How do CHMP2, 3, 4 and 6 assemblies form on membranes and dissociate in a VPS4 dependent manner? 2. What are the structures, composition and direction of growth of ESCRT-III assemblies as they mature on lipid membranes? 3. Since ESCRT-III polymer must form through the central pore of a membrane tubule, thereby posing a steric hindrance for fusion, how does pore closure followed by scission take place? 4. As CHMPs are predominantly cytosolic, how do their binding partners such as VPS4, AMSH (deubiquitin isopeptidase), and Alix (adaptor molecule) get selectively targeted to the membrane-bound fraction of CHMPs to exert their membrane proximal function? Answering the posed questions will not only advance our understanding of HIV egress from cells, it may also help open new therapeutic intervention points for several ESCRT-III related dysfunction. These studies will further form the basis for in vivo investigation of the mechanism by which ESCRT-III functions.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

FACEVAR (2013)

Face Recognition: Understanding the role of within-person variability

Read More  

FINLAB (2012)

Finance and Labor

Read More  

EVOLRECOMBADAPT (2014)

Recombination in Adaptive Evolution

Read More